SCHEMBL9511019

SCHEMBL9511019

O=CC(=Cc1cccnc1)c1ccccc1C(F)(F)F

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GAA P10253 2/20 0.46
CYP11B2 P19099 2/20 0.43
CYP19A1 P11511 1/20 0.43
KDM4E B2RXH2 3/20 0.40
MAPT P10636 3/20 0.40
MAPK1 P28482 2/20 0.40
KMT2A Q03164 2/20 0.40
ALDH1A1 P00352 2/20 0.40
ERN1 O75460 1/20 0.40
NOTUM Q6P988 1/20 0.39
CYP3A4 P08684 2/20 0.38
CYP11B1 P15538 1/20 0.38
RAB9A P51151 2/20 0.38
LMNA P02545 2/20 0.38
NPC1 O15118 1/20 0.38
JUN P05412 1/20 0.38
NFKB1 P19838 1/20 0.38
GPR55 Q9Y2T6 1/20 0.38
CYP1A1 P04798 1/20 0.38
CYP1A2 P05177 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9511016 1.00 GAA (0.46) GAACYP11B2CYP19A1KDM4EMAPT
SCHEMBL9507195 0.82 CYP11B2 (0.46) GAACYP11B2CYP19A1KDM4EMAPT
SCHEMBL9507197 0.82 CYP11B2 (0.46) GAACYP11B2CYP19A1KDM4EMAPT
SCHEMBL9509530 0.79 CYP11B2 (0.47) GAACYP11B2CYP19A1KDM4EMAPT
SCHEMBL9509528 0.79 CYP11B2 (0.47) GAACYP11B2CYP19A1KDM4EMAPT
SCHEMBL9509584 0.77 EPHX2 (0.45) CYP11B2CYP19A1KDM4EMAPTMAPK1
SCHEMBL9509587 0.77 EPHX2 (0.45) CYP11B2CYP19A1KDM4EMAPTMAPK1
SCHEMBL9724843 0.75 CYP11B2 (0.65) GAACYP11B2CYP19A1KDM4EMAPT
SCHEMBL9724840 0.75 CYP11B2 (0.65) GAACYP11B2CYP19A1KDM4EMAPT
SCHEMBL9507229 0.74 TSHR (0.49) CYP11B2CYP19A1KMT2AMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0298380-B1 PROCESS FOR THE PREPARATION OF ALPHA-BETA-SUBSTITUTED ACROLEINS BASF Aktiengesellschaft (DE) 1993-09-29 EP disclosed
US-4920232-A CHEMICAL INTERMEDIATES BASF AKTIENGESELLSCHAFT (DE) 1990-04-24 US disclosed
EP-0298380-A2 Process for the preparation of alpha-beta-substituted acroleins BASF Aktiengesellschaft (DE) 1989-01-11 EP disclosed